Kaizen Advisory’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$306K Buy
2,646
+352
+15% +$39.3K 0.21% 138
2018
Q3
$246K Hold
2,294
0.13% 152
2018
Q2
$196K Buy
2,294
+1,349
+143% +$111K 0.1% 161
2018
Q1
$73K Hold
945
0.07% 153
2017
Q4
$80K Buy
+945
New +$80.4K 0.05% 152

Other funds holding LLY

Kaizen Advisory's LLY Position: Q4 2018 in Review

Kaizen Advisory increased its Eli Lilly (LLY) stake by 15% in Q4 2018, buying an estimated $39.3K and bringing the position to 2,646 shares worth $306K. The position accounts for 0.21% of the portfolio, ranked #138.

Kaizen Advisory first reported a position in LLY in Q4 2017 and has held it in 5 quarters since. 1,560 funds tracked by Wall St. Rank hold LLY as of Q4 2018.

  • Kaizen Advisory held 2,646 shares of Eli Lilly worth $306K as of Q4 2018.
  • Kaizen Advisory bought 352 Eli Lilly shares in Q4 2018, an estimated $39.3K.
  • Eli Lilly made up 0.21% of Kaizen Advisory's portfolio in Q4 2018, its #138 holding.
  • Kaizen Advisory first reported a position in Eli Lilly in Q4 2017 and has held it in 5 quarters since.
  • 1,560 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2018.

Based on Kaizen Advisory's 13F filing for Q4 2018, filed 15 Feb 2019.